Validation of the Alopecia Areata Patient Priority Outcomes Questionnaire in Adults and Adolescents with Alopecia Areata

    November 2021 in “ Dermatology and Therapy ”
    Kathleen W. Wyrwich, Randall Winnette, Randall H. Bender, Kavita Gandhi, Nicole Williams, Nimanee Harris, Lauren Nelson
    TLDR The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.
    The study validated the Alopecia Areata Patient Priority Outcomes (AAPPO) questionnaire as a reliable and valid tool for assessing hair loss severity and its impact on individuals with alopecia areata (AA). This disease-specific measure was tested in both adults and adolescents, providing a standardized method to evaluate the condition's effects. The validation of the AAPPO questionnaire helped in understanding the patient-reported outcomes, which are crucial for both clinical assessments and therapeutic interventions in AA.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    6 / 1000+ results

      community Binding affinity of pyrilutamide!

      in Update  172 upvotes 3 years ago
      Pyrilutamide, a nonsteroidal antiandrogen drug under development for the potential treatment of androgenic alopecia. The conversation discusses its binding affinity to the androgen receptor and the timeline for possible availability after trials are completed in the United States and China.

      community Why I deleted my YouTube channel Part I

      in Update  118 upvotes 4 years ago
      A YouTuber named Kevin, also known as Rider_Of_Roach, who deleted his YouTube channel due to personal attacks and controversy surrounding his views on hair loss treatments. He advocated for FDA-approved treatments like finasteride and minoxidil but faced backlash from those who disagreed with him. The conversation also discusses his past trolling behavior and a lawsuit he filed against a website that published false information about him. Despite some disagreements, many viewers appreciated his research-based content and hope to see him return in the future.

      community So we’re just ok with taking a research chemical now?

      in Treatment  181 upvotes 4 years ago
      The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.

      community find a cure for this shit already

      in Chat  208 upvotes 5 years ago
      Treatments used to prevent and treat male pattern baldness, the difficulty in finding a permanent cure for hair loss, and the potential financial motivations of companies not wanting to find a cure.

    Related Research

    3 / 3 results